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Objective. To evaluate the frequency and clinical significance of non-tuberculous mycobacteria (NTM) isolates among children
investigated for pulmonary tuberculosis in a rural South African community. Methods. Children were investigated for
pulmonary tuberculosis as part of a tuberculosis vaccine surveillance program (2001–2005). The clinical features of children in
whom NTM were isolated, from induced sputum or gastric lavage, were compared to those with culture-proven M.
tuberculosis. Results. Mycobacterial culture demonstrated 114 NTM isolates from 109 of the 1,732 children investigated,
a crude yield of 6% (95% CI 5–7). The comparative yield of positive NTM cultures from gastric lavage was 40% (95% CI 31–50),
compared to 67% (95% CI 58–76) from induced sputum. 95% of children with NTM isolates were symptomatic. Two children
were HIV-infected. By contrast, M. tuberculosis was isolated in 187 children, a crude yield of 11% (95% CI 9–12). Compared to
those with culture-proven M. tuberculosis, children with NTM isolates were less likely to demonstrate acid-fast bacilli on direct
smear microscopy (OR 0.19; 95% 0.0–0.76). Children with NTM were older (p,0.0001), and more likely to demonstrate
constitutional symptoms (p=0.001), including fever (p=0.003) and loss of weight or failure to gain weight (p=0.04), but less
likely to demonstrate a strongly positive tuberculin skin test (p,0.0001) or radiological features consistent with pulmonary
tuberculosis (p=0.04). Discussion. NTM were isolated in 6% of all children investigated for pulmonary tuberculosis and in
more than one third of those with a positive mycobacterial culture. NTM may complicate the diagnosis of PTB in regions that
lack capacity for mycobacterial species identification. The association of NTM isolates with constitutional symptoms suggestive
of host recognition requires further investigation.
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INTRODUCTION
The diagnosis of pulmonary tuberculosis (PTB) in children is
difficult, since disease is often pauci-bacillary [1]. Bacteriological
confirmation of M. tuberculosis in children may be possible in fewer
than 40% of suspect cases, yet it remains the gold standard in
the majority of diagnostic approaches [1]. In practice, high-
prevalence, resource-limited countries rely on history-taking,
tuberculin skin testing, and chest radiography, for investigation
of PTB in children [1]. Gastric lavage or induced sputum sampling
may not be feasible in many developing country settings, and even
if smear microscopy is performed, mycobacterial culture or PCR
for species identification may not be available, with the result that
a diagnosis of M. tuberculosis will be made if any acid-fast bacilli are
detected [1].
Non-tuberculous mycobacteria (NTM) are ubiquitous environ-
mental acid-fast bacilli, which are present in water, soil, and
biofilms [2]. Since NTM are resistant to chlorine and biocide
disinfection, they frequently contaminate municipal drinking water
distribution systems [2–3]. Although NTM are not obligate
pathogens, they share the features of hardiness, hydrophobicity,
aerosolization, and intracellular pathogenicity, with M. tuberculosis
[2]. The probability of NTM disease is likely to increase with
the extent of environmental exposure, particularly in farming
communities, with immune susceptibility to opportunistic in-
fection, and with co-existent chronic lung disease such as cystic
fribrosis [2–4]. However, a recent review of the English literature
over a period of 70 years describes 43 cases of pulmonary disease
caused by NTM in previously well children [5]. In contrast,
cervical lymphadenitis is a relatively common mode of pre-
sentation in childhood [6]. Increased awareness of NTM, and
improved methods of detection, may make it increasingly difficult
to distinguish NTM disease from environmental colonization [2].
It might also be difficult to distinguish tuberculous from non-
tuberculous mycobacterial lung disease on the basis of clinical and
radiological features [5]. Detection of non-tuberculous acid-fast
bacilli in respiratory secretions by direct smear microscopy might
be misinterpreted as PTB unless mycobacterial species identifica-
tion is available [7]. In this region, the relative prevalence of M.
tuberculosis and NTM in respiratory secretions, and therefore the
magnitude of this diagnostic dilemma in the diagnosis of childhood
PTB, remains unknown [1].
These issues are clearly important for the diagnosis and
treatment of childhood tuberculosis, but are also crucial in the
design of precise clinical and microbiological endpoints for trials of
novel tuberculosis vaccines in these regions. Meta-analyses of
previous trials of bacille Calmette-Guerin (BCG) vaccination
concluded that protection due to BCG was better in trials
reporting laboratory-confirmed cases of tuberculosis and that
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[8]. It has also been suggested that greater exposure to environ-
mental mycobacterial antigens in tropical and sub-tropical
latitudes might be responsible for the reduced efficacy of BCG
vaccine trials in these regions [9]. We aimed to determine the
frequency and clinical significance of NTM isolates among
children investigated for PTB at a tuberculosis vaccine trial site
in a rural South African community.
METHODS
This community-based study was carried out at a tuberculosis
vaccine trial site in a rural area 100 km outside Cape Town, South
Africa. The region is a wheat, fruit, and sheep farming area with
a population of approximately 350 000, serviced by 4 primary and
secondary level hospitals and a network of day clinics. Almost
90% of households have formal housing, 70% are supplied with
electricity, and 65% are supplied with sanitation and piped water
[10]. In 2003, the infant mortality rate was 28 per 1000 live births
and the incidence of PTB was 583 per 100 000 [10]. In the South
African context, the antenatal Human Immunodeficiency Virus
(HIV) sero-prevalence rate has been relatively low at 8% [10].
Children with possible PTB were prospectively identified during
surveillance of 11677 children enrolled in an ongoing phase 4
BCG vaccine trial (2001–2005). Passive surveillance included
perusal of hospital admission records, radiology reports, tubercu-
losis registers, and communication with district clinic staff
throughout the study area. Active surveillance was not conducted
and therefore data from children who did not come into contact
with the health services, or tuberculosis control programme, were
not collected. Indications for investigation included a known adult
contact with PTB, or recent attendance at public sector health
services with an illness consistent with PTB. Children were then
admitted to the trial Case Verification Ward at the regional
tuberculosis hospital for diagnostic purposes, with the written
informed consent of the parent or legal guardian. Subsequent out-
patient treatment for PTB, if indicated, was managed by the
regional tuberculosis control programme, with a follow-up visit to
evaluate adherence to treatment. The trial was approved by the
Research Ethics Committee of the University of Cape Town and
monitored by a Data Safety Monitoring Board (DSMB).
The following data were prospectively collected: age; weight;
a history of fever, night sweats, recent loss of weight, cough, or
wheeze; and respiratory rate, lymphadenopathy, or lung crepita-
tions, on clinical examination. Failure to gain weight was defined
as crossing of weight-for-age centiles on the Road-To-Health card.
Weight-for-age Z scores were calculated using Epi Info
TM Version
3.3.2 (Centers for Disease Control and Prevention, Department of
Health and Human Services, USA), based upon the 2000 CDC
reference values. Percentage oxygen saturation was measured by
pulse oximetry. Mantoux and Tine tuberculin skin tests were
performed in all children, as well as a chest radiograph, and a rapid
HIV test (with confirmatory HIV ELISA and PCR, if positive).
The chest radiograph was graded by an experienced tuberculosis
clinician, primarily on the basis of hilar or paratracheal
lymphadenopathy, with or without atelectasis or consolidation,
as either ‘normal’; ‘abnormal, but not PTB’; ‘suspicious of PTB’;
or ‘likely to be PTB’. For the purpose of comparison, these four
categories were further compressed to a binary variable, either
‘suggestive’ or ‘not suggestive’ of PTB.
Two gastric lavage and two induced sputum samples were
obtained on consecutive days, using a modified method, previously
described, which has been shown to be effective in infants
and children less than 2 years of age [11]. Sterile single-use
consumables were used for each clinical procedure. Laboratory
procedures were carried out at an accredited laboratory (South
African National Accreditation Service) with international quality
control provided by the National External Quality Assurance
Service (NEQAS). Specimens were decontaminated using stan-
dard laboratory procedures. Briefly, specimens were mixed with
equal volumes of 6% NaOH/2,9% Na citrate and N-acetyl
cysteine and left for 15 minutes. Neutralization was achieved by
the addition of phosphate buffered saline (pH 6,8). These were
then centrifuged for 15 minutes, the supernatant discarded, and
the deposit re-suspended in phosphate buffer. A smear was
prepared from this deposit and stained using the auramine O
fluorescent stain. An aliquot of the deposit was inoculated into
a Mycobacterial Growth Indicator Tube (MGIT) according to the
manufacturer’s instructions (Becton Dickinson and Company,
Sparks, Md, USA), and onto Lowenstein-Jensen agar slopes.
Cultures were incubated for 8 weeks before being recorded as
negative.
Positive cultures were screened by Ziehl-Neelsen and Gram
stain. Those cultures showing acid-fast bacilli were identified as
Mycobacterium tuberculosis complex by the Accuprobe M. tuberculosis
complex culture identification test, according to the manufac-
turer’s instructions (Gen-Probe, San Diego, Ca, USA). Those
cultures positively identified by the Accuprobe test were further
identified by a PCR assay to differentiate M. bovis BCG from other
members of the M. tuberculosis complex [12].
If the Accuprobe assay was negative, isolates were identified as
M. tuberculosis by PCR as previously described [13]. Amplification
of a 336bp band using this assay served to identify the organism as
M. tuberculosis. Cultures showing no amplification with this PCR
assay were further identified by a second assay as described by
Telenti et al and modified by Brunello et al [14–15]. Briefly,
a portion of the hsp65 gene was amplified, and the resultant 439bp
product digested by the restriction enzymes BstEII and HaeIII. The
sizes of the fragments generated were used to identify the
organisms to species level. If the organism morphologically
appeared to be one of the other aerobic actinomycetes, and had
not been identified by the restriction enzymes as described above,
the hsp65 amplicon was digested with MspI and HinfI, and the
identity of the organism determined by using the algorithm
described by Steingrube et al [16].
The crude yield of mycobacterial culture for NTM was
calculated as a proportion of all children who underwent
investigation. The comparative yield of NTM culture from gastric
lavage and induced sputum was calculated as a proportion of all
children from whom NTM were isolated. Children from whom
both NTM and M. tuberculosis were isolated were included in the
comparison of diagnostic yields from either gastric lavage or
induced sputum, but were excluded from the comparison of
symptoms and clinical signs associated with either NTM or M.
tuberculosis.
Reports of positive culture results and a summary of clinical
findings and investigations were provided to the regional health
services and tuberculosis control programme for ongoing man-
agement. Children in whom PTB was diagnosed were routinely
treated for 6 months (2 months rifampicin, isoniazid, and
pyrazinamide; 4 months rifampicin and isoniazid) and followed
to completion of treatment by means of a clinic register. During
the data collection period, NTM were thought to be environmen-
tal contaminants in children without immune deficiency or
underlying chronic lung disease, rather than pathogens, and
therefore specific antibiotic therapy for NTM was not routinely
recommended. In-patient records of all subsequent hospital
admissions for respiratory illness were examined and a study
follow-up visit was conducted for children in whom PTB was
Non-Tuberculous Mycobacteria
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patient clinic attendances, general practitioner visits, and antibiotic
prescription records were not collected by the surveillance system.
Data are presented as n (%), 95% confidence intervals (95% CI)
for proportions, and median and inter-quartile range (IQR) for
continuous data. Categorical data were analyzed by the Fisher’s
Exact test or Chi-squared test, as appropriate, and continuous data
were analyzed by the Mann-Whitney test, using Analyse-It
statistical software (Analyse-It, UK).
RESULTS
Over a period of 4 years (2001–2005), 1732 children (15%) had
been admitted for investigation at the time of analysis. Mycobac-
terial culture had yielded 72 identifiable NTM isolates, comprising
8 different species, and 37 non-identifiable NTM, from 215 gastric
lavage and 214 induced sputum specimens, in 109 children (see
Table 1). Initial direct smear microscopy had demonstrated scanty
acid-fast bacilli in two children. All gastric lavage and induced
sputum specimens from the remaining 107 children had been
direct smear microscopy negative. Two or more NTM species
were isolated in 4 children, and 5 children were co-infected with
M. tuberculosis.
The crude yield of mycobacterial culture for NTM (n=109)
was 6% (95% CI 5–7) overall; 3% (95% CI 2–3) from gastric
lavage (n=44); and 4% (95% CI 3–5) from induced sputum
(n=73). NTM were demonstrated by both gastric lavage and
induced sputum in 8 children. The comparative yield of NTM
culture (n=109) was 40% (95% CI 31–50) for gastric lavage
(n=44), compared to 67% (95% CI 58–76) for induced sputum
(n=73). The comparative yield of NTM culture for the two most
common species, M. intracellulare (n=47) and M. gastri (n=7), was
30% (95% CI 17–43) and 57% (95% CI 20–94) for gastric lavage,
compared to 74% (95% CI 62–87) and 71% (95% CI 38–100) for
induced sputum.
For comparison, the crude yield of mycobacterial culture for M.
tuberculosis (n=187) was 11% (95% CI 9–12), resulting in a yield
ratio of tuberculous to non-tuberculous mycobacteria of less than
2:1. An additional 51 children (3%; 95% CI 2–4) had been positive
or scanty positive for acid-fast bacilli on direct smear microscopy,
but subsequently mycobacterial culture and PCR negative.
Among children with a positive mycobacterial culture, those with
NTM isolates were less likely to have had acid-fast bacilli detected
on initial direct smear microscopy, odds ratio 0.19 (95% CI 0.0–
0.76), than those with M. tuberculosis. See Figure 1.
Clinical data in children with NTM isolates
The clinical features of children from whom NTM alone were
isolated (n=104) are summarized in Table 2. Only 4 children
(4%) had lymphadenopathy, which was cervical and without
adenitis in all cases. Median baseline respiratory rate was 28 per
minute (26–30). Respiratory symptoms and signs included cough
(n=58; 56%), wheeze (n=51; 49%); and lung crepitations (n=26;
25%), but no children demonstrated sub-costal recession. Only 5
children (5%) were entirely well, without any constitutional or
respiratory symptoms or signs.
Table 1. Non-tuberculous mycobacterial isolates (n=114)
obtained from gastric lavage or induced sputum specimens in
children investigated for tuberculosis (n=109).
......................................................................
Isolates of non-tuberculous Mycobacteria alone
Identifiable non-tuberculous Mycobacteria n=72 63%
M. intracellulare n=47 41%
M. gastri n=7 6%
M. avium n=5 4%
M. gordonae n=5 4%
M. flavescens n=3 3%
M. scrofulaceum n=3 3%
M. szulgai n=1 1%
M. kansasii n=1 1%
Non-identifiable non-tuberculous mycobacteria n=37 32%
Isolates in association with M. tuberculosis
Identifiable non-tuberculous Mycobacteria n=4 4%
M. intracellulare n=4 4%
Non-identifiable non-tuberculous mycobacteria n=1 1%
doi:10.1371/journal.pone.0000021.t001
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Figure 1. Distribution of children with NTM (n=104) or M. tuberculosis (n=182) isolates according to whether acid-fast bacilli (AFB) were detected on
initial direct smear microscopy. Children with dual NTM and M. tuberculosis isolates (n=5) are excluded. Proportions are presented as a percentage of
Direct Smear AFB+(n=70) or Direct Smear AFB–children (n=1662). Data are n (%).
doi:10.1371/journal.pone.0000021.g001
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was 100% (99–100). A total of 31 children (30%) demonstrated
either a strongly positive Mantoux (./=15 mm), or Tine reaction
(Grade 3 or 4). Ninety-three children (89%) were tested for HIV,
of whom none were HIV-infected. An additional 2 children with
NTM isolates (M. intracellulare and M. gordonae respectively) were
found to have been tested and diagnosed as HIV-infected prior to
admission.
At the time of ward discharge, 7 chest radiographs (7%) were
classified by the treating clinician as ‘likely to be PTB’, 27 (26%) as
‘suspicious of PTB’, and 11 (11%) as ‘abnormal, but not consistent
with PTB’. On the basis of the clinical and radiological findings,
46 children (44%) were presumptively diagnosed as having PTB at
the time of ward discharge and were referred to the health services
for anti-tuberculous therapy.
Follow-up data in children with NTM isolates
Six children from whom NTM had been isolated were sub-
sequently hospitalized for pneumonia (lobar pneumonia n=3;
bronchopneumonia n=3) at intervals ranging from 2 weeks to
7 months after discharge from the Case Verification Ward. All 6
children recovered fully after treatment with either penicillin or
a cephalosporin. One child, who had been presumptively
diagnosed with PTB and treated with 6 months of anti-
tuberculous drugs, was later hospitalized for a second time with
a diagnosis of tuberculous meningitis.
Sixty-eight children with NTM isolates (62%) received a follow-
up visit, of whom 42 (39%) were asymptomatic; 16 children (15%)
were symptomatic (including one child with cervical lymphade-
nopathy) and were referred for investigation and possible
treatment of suspected NTM disease; 9 children were found to
have left the study area; and 1 HIV-infected child had died. No
children had received in-patient or out-patient antibiotic treatment
for NTM disease at the time of follow-up, although 18 (17%) of the
asymptomatic and 7 (6%) of the symptomatic children had been
treated for PTB.
Comparison of children with NTM and M.
tuberculosis isolates
As shown in Table 2, children with NTM isolates were older
(p,0.0001), and more likely to report constitutional symptoms
(p=0.001), such as fever (p=0.003), and either loss of weight or
failure to gain weight (p=0.04), than children from whom M.
tuberculosis was isolated. Although children with NTM isolates did
not have a higher frequency of respiratory symptoms (p=0.46), or
signs (p=0.16), they were more likely to demonstrate a combina-
tion of both constitutional and respiratory abnormalities
(p=0.009).
Sixty-eight children (65%) from whom NTM were isolated
demonstrated a negative (ie. completely unreactive) Mantoux
tuberculin skin test, compared to 65 children (36%) with M.
tuberculosis isolates (p,0.0001). The median size of the reaction to
the Mantoux tuberculin skin test was 0 mm (IQR 0–9) in children
with NTM, compared to 12 mm (IQR 0–20) in children with M.
tuberculosis (p,0.0001). Similarly, children with NTM isolates
demonstrated a median Grade 1 (IQR 0–2) Tine reaction,
compared to Grade 2 (IQR 0–4) in those with M. tuberculosis
(p=0.0001). The size of the Mantoux reaction demonstrated only
moderate ability to discriminate M. tuberculosis from NTM, with
area under the receiver operating characteristic (ROC) curve of
0.67 (95% CI 0.60–0.73), (p,0.001). See Figure 2.
When the classification of chest radiographs by the treating
clinician was compressed to a binary variable (ie. suggestive or not
suggestive of PTB), 33% of chest radiographs from children with
NTM (n=34) were suggestive of PTB, compared to 45% of chest
radiographs from those with M. tuberculosis (n=82), (p=0.04).
DISCUSSION
We have demonstrated in a rural South African community that
NTM were isolated in 6% of all children who were investigated for
PTB, and in more than one third of those with a positive
mycobacterial culture. This is an agricultural area and children in
Table 2. Comparison of demographic and clinical features in children from whom either M. tuberculosis, (n=182) or non-
tuberculous Mycobacteria (n=104) were isolated. Children with dual NTM and M. tuberculosis isolates (n=5) are excluded. Data are
n (%) or median (IQR).
..................................................................................................................................................
M. tuberculosis Non-tuberculous Mycobacteria p value
Age (months) 10 (5.0–16) 18 (13–23) ,0.0001
Weight-for-age Z score 21.0 (21.4 to 20.7) 20.8 (21.1 to 20.6) 0.37
Loss of weight or failure to gain weight n=74 (41%) n=56 (54%) 0.04
Loss of weight n=57 (31%) n=33 (32%) 0.93
Failure to gain weight n=58 (32%) n=45 (43%) 0.07
Fever or night sweats n=93 (51%) n=72 (69%) 0.004
Fever n=49 (27%) n=47 (45%) 0.003
Night sweats n=78 (43%) n=47 (45%) 0.86
Any constitutional symptom n=121 (66%) n=88 (85%) 0.001
Cough n=103 (57%) n=58 (56%) 0.91
Any respiratory symptom n=124 (68%) n=76 (73%) 0.46
Any respiratory sign n=78 (43%) n=35 (34%) 0.16
Any constitutional or respiratory symptom or sign n=161 (88%) n=99 (95%) 0.08
Both constitutional and respiratory symptoms or signs n=94 (52%) n=71 (68%) 0.009
doi:10.1371/journal.pone.0000021.t002
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environmental NTM than their urban counterparts [2,4]. This
hypothesis is supported by the finding that children with NTM
isolates were significantly older than those from whom M.
tuberculosis was cultured, consistent with increased environmental
soil exposure in older ambulant toddlers. However, the high
recovery rate of NTM may also be related to the technique used to
obtain clinical samples. The yield of NTM from induced sputum
culture was greater than that from gastric lavage, particularly in
the case of M. intracellulare. These findings are similar to those of
a previous diagnostic study in childhood PTB, suggesting that
induced sputum is a superior technique for detection of both
tuberculous and non-tuberculous mycobacteria [11].
There have been few reports of NTM lung disease in otherwise
well children, although cervical adenitis is relatively common in
childhood [5–6]. We have prospectively documented isolation of
NTM from respiratory secretions in more than a hundred
children, the majority of whom were symptomatic. Great caution
should be exercised in labeling these as cases of NTM lung disease,
even though children with NTM isolates exhibited symptoms
consistent with host recognition, rather than environmental
colonization. The majority of the NTM species were respiratory
pathogens known to cause intrathoracic disease, and previous
reports of pediatric NTM disease have also documented a pre-
dominance of M. avium intracellulare complex, consistent with our
findings [5,6,17]. It is notable that compared to children with
microbiologically confirmed M. tuberculosis, those children from
whom NTM were isolated were even more likely to display
constitutional symptoms compatible with disease. However,
although these constitutional symptoms occurred in association
with respiratory symptoms or signs, children with NTM isolates
were less likely to demonstrate supporting radiographic features
compatible with pulmonary disease. Lastly, although the natural
history of NTM disease is not known, the majority of children
recovered without specific antibiotic therapy for NTM.
It may be difficult to distinguish the etiology of lung disease in
children with suspected PTB, since common respiratory symptoms
and signs were associated with both NTM and M. tuberculosis
isolates. In developing regions, a presumptive diagnosis of
childhood PTB is often made on the basis of clinical features,
a tuberculin skin test, and chest radiography, without bacterio-
logical confirmation [1]. However, interpretation of chest radio-
graphy may be variable, pulmonary disease caused by NTM has
a similar radiographic picture to that of M. tuberculosis, and it has
been suggested that response to tuberculin skin testing may
represent partial cross-reactivity to NTM antigens [17–18].
Therefore, taking into account a high index of suspicion related
to the regional prevalence of tuberculosis, it is not surprising that
PTB had been diagnosed in many of these children before
mycobacterial culture results became available.
Isolation of NTM should not rule out tuberculosis as the cause
of pulmonary disease, since the constitutional symptoms associated
with NTM isolates might have been due to undiagnosed, culture-
negative tuberculosis. However, given the lesser reaction of
children with NTM to tuberculin skin testing, this does not
appear to be the case. It is also notable that only two of the
children with NTM isolates were HIV-infected, which may reflect
either low maternal HIV infection rates, or the success of
interventions aimed at decreasing perinatal HIV transmission
[10]. Although the remainder of the children was not formally
investigated for immuno-deficiencies other than HIV infection, the
majority were assumed to be immuno-competent.
Since clinicians in resource-limited settings rely primarily on
clinical and radiological diagnostic techniques for investigation of
suspected PTB in children, it would be difficult to differentiate
symptomatic NTM from tuberculous disease without microbio-
logical confirmation [1]. It is doubly unfortunate that this region,
which has high prevalence rates of PTB, also appears to have high
levels of exposure to environmental NTM [10]. The yield ratio of
M. tuberculosis to NTM culture was less than 2:1, suggesting that
Figure 2. Receiver Operating Characteristic plot of Mantoux tuberculin skin test reaction (mm) for differentiation of M. tuberculosis from NTM isolates.
Area under the curve (AUC) 0.67 (95% CI 0.60–0.73) (p,0.0001).
doi:10.1371/journal.pone.0000021.g002
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detected in respiratory secretions. However, since children with
NTM isolates were less likely to demonstrate acid-fast bacilli on
direct smear microscopy, this potential diagnostic dilemma may
not be relevant in practice. The identities of the acid-fast bacilli
seen on smear microscopy, but which did not grow on subsequent
culture, are unknown. This phenomenon may reflect vigorous
decontamination during specimen handling, or inherent difficulty
in isolating one or more mycobacterial species on culture.
The newer immunodiagnostic assays for M. tuberculosis might not
completely avoid these diagnostic difficulties, since several of the
organisms isolated in this study, such as M. szulgai, M. flavescens,
and M. gastri, also possess RD1-encoded antigens [18–19].
However, the lesser reaction of children with NTM to tuberculin
skin testing, and the large proportion of unreactive Mantoux tests,
suggests that cross-reactivity between M. tuberculosis and NTM
antigens may be less of a confounding issue than has been thought
[18]. The data suggest that tuberculin skin testing might still be
useful in differentiating children with NTM from those with M.
tuberculosis, although with only moderate discriminatory ability.
This study has several important limitations that should be
considered when interpreting the data. Children were investigated
only if they were thought to be at risk of PTB, due to a suspect
illness or tuberculosis contact, which introduces an ascertainment
bias. Since we are unable to determine the background NTM
contamination rate in a control group, we have attempted to
overcome this factor by comparing only children with culture-
confirmed NTM or M. tuberculosis, thereby excluding all those who
might have had undiagnosed culture-negative disease of either
aetiology. Secondly, we report subjective and objective clinical
features, in association with microbiological evidence, but the
radiological and histological evidence that would be required to
demonstrate an association between the recovery of NTM and
lung pathology is lacking. Only 2 children had been direct smear
positive for acid-fast bacilli, only 8 children demonstrated NTM
isolates on more than one culture, and only a third of chest
radiographs were suggestive of mycobacterial lung disease, so that
few of these cases would meet the American Thoracic Society
criteria for the diagnosis of NTM lung disease [20]. However,
since such stringent criteria would be inappropriate for the
diagnosis of childhood PTB, it could equally be argued that these
criteria should not be applied to the diagnosis of NTM disease in
children [1].
It is also possible that decontamination procedures contributed
to the high ‘smear positive culture negative’ rate and that the true
rate of isolation of NTM, or M. tuberculosis, is even higher than that
reported. Conversely, it is conceivable that laboratory contami-
nation may have produced some false positive NTM isolates, but
since 8 different NTM species were demonstrated, it is unlikely
that systematic NTM contamination occurred. Finally, since
follow-up surveillance collected only hospital data, we are unable
to report duration of symptoms in the out-patient setting. For the
above reasons, the intriguing relationship between NTM isolates
and constitutional symptoms deserves further investigation, but
should not be over-interpreted as a causal association with NTM
disease.
Several other questions remain unanswered. The burden of
environmental NTM exposure in this rural community is not
known, nor is the prevalence of respiratory tract colonization
among well children. This region of South Africa has one of the
highest incidence rates of PTB in the world, and since it has been
suggested that exposure to environmental NTM might adversely
affect the protective immunity imparted by BCG vaccination, the
relationship between NTM isolation and the high incidence of
PTB in this region requires exploration [9,10,21]. In the context of
future phase 3 trials of novel tuberculosis vaccines, the prevalence
of mycobacteria other than M. tuberculosis should be taken into
account when drafting the clinical, radiological, and microbiolog-
ical diagnostic criteria for the primary outcome, ie. childhood
tuberculosis. It remains to be seen whether the immunogenicity
and efficacy of such tuberculosis vaccines might be affected by
exposure to environmental NTM antigens, as in the case of BCG
[9,21]. We suggest that the rate of isolation of NTM should be
analysed as a potential confounder when comparing future
tuberculosis vaccine trials in different geographical areas.
In conclusion, we have demonstrated that NTM were isolated
in 6% of all children investigated for PTB, and in more than a third
of those with a positive mycobacterial culture, with the highest
yield coming from induced sputum. Children with NTM isolates
were less likely to demonstrate acid-fast bacilli on initial direct
smear microscopy than those with M. tuberculosis. Nevertheless, the
presence of NTM further complicates the diagnosis of childhood
PTB in resource-limited countries with limited capacity for
microbiological confirmation and mycobacterial species identifi-
cation.
Children with NTM isolates were more likely to report
constitutional symptoms, but demonstrated less reaction to
tuberculin skin testing, than children with M. tuberculosis. The
association of NTM isolates with symptoms suggestive of host
recognition, among immuno-competent children without un-
derlying chronic lung disease, requires further investigation, but
should not be over-interpreted as NTM disease.
These findings should be taken into account when designing
clinical trials for novel tuberculosis vaccines in developing
countries, where exposure to environmental NTM might affect
both accuracy of the diagnostic endpoint and immunogenicity of
the trial vaccine.
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